Asingua, Baby Girl .

HRN: 23-34-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/23/2023
07/30/2023
IV
55mg
OD
PSNB
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: